These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3032227)

  • 21. Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements.
    Daoud EG; Man KC; Horwood L; Morady F; Strickberger SA
    Am J Cardiol; 1997 Jan; 79(1):97-100. PubMed ID: 9024750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
    Nattel S
    J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of amiodarone and desethylamiodarone in human plasma by high performance liquid chromatography.
    Mamolo MG; Vio L; Furlan G
    Farmaco; 1992; 47(7-8):1067-80. PubMed ID: 1445614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone and multilamellar inclusion bodies.
    Somani P; Bandyopadhyay S; Gross SA; Morady F; Dicarlo LA
    Br J Clin Pharmacol; 1987 Aug; 24(2):237-9. PubMed ID: 3040059
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
    Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of plasma concentration of amiodarone and desethylamiodarone with high pressure liquid chromatography. Preliminary experience].
    Saavedra I; Ortiz M; Gaete L; Asenjo R; Biagini L
    Rev Med Chil; 1992 Jun; 120(6):661-5. PubMed ID: 1341797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of increased hepatic density during chronic amiodarone therapy].
    Hirakawa K; Abe K; Ayabe Y; Nishimura M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 May; 63(5):221-4. PubMed ID: 12822447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of amiodarone and its metabolite desethylamiodarone in human plasma and serum.
    Paczkowski D; Popławska W; Filipek M; Podleśny J
    Pol J Pharmacol Pharm; 1989; 41(4):359-67. PubMed ID: 2634829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.
    Marchiset D; Bruno R; Djiane P; Cano JP; Benichou M; Serradimigni A
    Biopharm Drug Dispos; 1985; 6(2):209-15. PubMed ID: 4005397
    [No Abstract]   [Full Text] [Related]  

  • 31. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous and oral amiodarone for arrhythmias in children.
    Bucknall CA; Keeton BR; Curry PV; Tynan MJ; Sutherland GR; Holt DW
    Br Heart J; 1986 Sep; 56(3):278-84. PubMed ID: 3756044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone pharmacokinetics in coronary patients: differences between acute and one-month chronic dosing.
    Poirier JM; Escoubet B; Jaillon P; Coumel P; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1988; 13(1):67-72. PubMed ID: 3396616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
    Lee P; Kirk RG; Reasor MJ
    Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity.
    Lafuente-Lafuente C; Alvarez JC; Leenhardt A; Mouly S; Extramiana F; Caulin C; Funck-Brentano C; Bergmann JF
    Br J Clin Pharmacol; 2009 May; 67(5):511-9. PubMed ID: 19552745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.
    Liu FL; Cohen RD; Downar E; Butany JW; Edelson JD; Rebuck AS
    Thorax; 1986 Feb; 41(2):100-5. PubMed ID: 3010484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
    Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
    In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of amiodarone in serum samples under various storage conditions.
    Vuagnat A; Goedel-Meinen L; Gries E; Hofmann M; Presch A; Blömer H
    Arzneimittelforschung; 1993 Mar; 43(3):327-30. PubMed ID: 8489561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone.
    Manfredi C; Clerico A; Iervasi G; Turchi S; Cazzuola F; Berti S; Sabatino L; Biagini A
    Int J Clin Pharmacol Res; 1995; 15(2):87-93. PubMed ID: 8593976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.